If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Doctor of Pharmacy, Université de Liège (ULg)

Award Date: 30 Jun 2000

Fingerprint Dive into the research topics where Jean-Michel DOGNE is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies

Favresse, J., Eucher, C., Elsen, M., Marie, T-H., Dogné, J-M. & Douxfils, J., 2020, In : Clinical Chemistry. 7 p.

Research output: Contribution to journalArticle

File

Il faut rappeler que le 'risque zéro' n’existe pas: chronique 3 - covid-19

Flohimont, V., DOGNE, J-M. & FAUVILLE, MARIE-ALINE. (ed.), 4 May 2020, HR Square.

Research output: Book/Report/JournalCommissioned report

Open Access
File
3 Downloads (Pure)
  • File
  • Datasets

    CCDC 1017214: Experimental Crystal Structure Determination

    Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J. (Contributor), Pirotte, B. (Contributor), Renard, J. (Contributor) & WINUM, J. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014

    Dataset

    CCDC 1017215: Experimental Crystal Structure Determination

    Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J. (Contributor), Pirotte, B. (Contributor), Renard, J. (Contributor) & WINUM, J. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014

    Dataset

    Prizes

    Prix Léo Pharma Cancer & Thrombosis

    Haguet, Helene (Recipient), DOUXFILS, JONATHAN (Recipient), MULLIER, Francois (Recipient) & DOGNE, Jean-Michel (Recipient), 25 Feb 2017

    Prize: Prize (including medals and awards)

    Activities

    • 6 Oral presentation

    Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

    21 Mar 2019

    Activity: Talk or presentation typesOral presentation

    In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), , François Mullier (Speaker), & Jean-Michel Dogne (Speaker)

    9 Feb 2018

    Activity: Talk or presentation typesOral presentation

    Risk of vascular occlusive events with BCR-ABL TKIs in CML

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

    25 Feb 2017

    Activity: Talk or presentation typesOral presentation

    Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

    28 Apr 2016

    Activity: Talk or presentation typesOral presentation

    Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis

    Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)

    29 Jan 2016

    Activity: Talk or presentation typesOral presentation